Study GMS-PH-001 is a multicenter, open-label, non-randomized study to prospectively evaluate screening strategies of pulmonary hypertension (PH) in patients with interstitial lung disease (ILD).
Interstitial Lung Disease, Pulmonary Hypertension
Study GMS-PH-001 is a multicenter, open-label, non-randomized study to prospectively evaluate screening strategies of pulmonary hypertension (PH) in patients with interstitial lung disease (ILD).
Pulmonary Hypertension Screening in Patients With Interstitial Lung Disease for Earlier Detection
-
Pulmonary Associates, Phoenix, Arizona, United States, 85032
Hartford Hospital, Hartford, Connecticut, United States, 06106
Lakeland Regional Health, Lakeland, Florida, United States, 33805
NCH Healthcare System, Naples, Florida, United States, 34102
University of South Florida Health, Tampa, Florida, United States, 33606
Cleveland Clinic Florida, Weston, Florida, United States, 33331
Emory University Hospital, Atlanta, Georgia, United States, 30322
Piedmont Healthcare, Austell, Georgia, United States, 30106
Loyola University Chicago, Chicago, Illinois, United States, 60153
Northwestern University, Chicago, Illinois, United States, 60611
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
For general information about clinical research, read Learn About Studies.
18 Years to
ALL
No
United Therapeutics,
2025-06